You are here: Welcome » Amanda Cohn

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
amanda_cohn [2022/04/21 23:14]
liam 		amanda_cohn [2024/12/18 19:23] (current)
liam [COVID-19]
Line 12: Line 12:
 ===== Career and Affiliations ===== ===== Career and Affiliations =====
  
-==== Centres for Disease Control and Prevention ====+==== Centers for Disease Control and Prevention ====
  
 Cohn is the Director of the Division of Birth Defects and Infant Disorders under the [[Center for Disease Control and Prevention|US Centers for Disease Control and Prevention]] (CDC).((CDC. (2021, December 17). //Amanda Cohn | Biographies | About Us | NCBDDD | CDC.// Centers for Disease Control and Prevention. https://archive.ph/bixnF)) In this role, she acts as a liaison representative on the [[National Advisory Committee on Immunization]] (NACI), responsible for approving [[COVID-19 vaccines]] in Canada.((//National Advisory Committee on Immunization (NACI): Membership and representation.// (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html)) Cohn is the Director of the Division of Birth Defects and Infant Disorders under the [[Center for Disease Control and Prevention|US Centers for Disease Control and Prevention]] (CDC).((CDC. (2021, December 17). //Amanda Cohn | Biographies | About Us | NCBDDD | CDC.// Centers for Disease Control and Prevention. https://archive.ph/bixnF)) In this role, she acts as a liaison representative on the [[National Advisory Committee on Immunization]] (NACI), responsible for approving [[COVID-19 vaccines]] in Canada.((//National Advisory Committee on Immunization (NACI): Membership and representation.// (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html))
Line 28: Line 28:
 ==== Forum on Microbial Threats ==== ==== Forum on Microbial Threats ====
  
-Cohn has participated numerous times on the planning committee for the [[Forum on Microbial Threats]], chaired by [[EcoHealth Alliance]] President [[Peter Dazsak]].((//PLANNING COMMITTEE ON THE CRITICAL PUBLIC HEALTH VALUE OF VACCINES: TACKLING ISSUES OF ACCESS AND HESITANCY.// (2021). In www.ncbi.nlm.nih.gov. National Academies Press (US). https://www.ncbi.nlm.nih.gov/books/NBK572616/)) +Cohn has participated numerous times on the planning committee for the [[Forum on Microbial Threats]], chaired by [[EcoHealth Alliance]] President [[Peter Daszak]].((//PLANNING COMMITTEE ON THE CRITICAL PUBLIC HEALTH VALUE OF VACCINES: TACKLING ISSUES OF ACCESS AND HESITANCY.// (2021). In www.ncbi.nlm.nih.gov. National Academies Press (US). https://www.ncbi.nlm.nih.gov/books/NBK572616/)) ((Forum on Microbial Threats. (2021). //The Critical Public Health Value of Vaccines// (J. Liao, C. Minicucci, & A. Nicholson, Eds.). National Academies Press. https://doi.org/10.17226/26134))
 ===== Research ===== ===== Research =====
  
Line 39: Line 38:
  
 Cohn was a co-author on the study identifying the first [[SARS-CoV-2]] infection in the United States, published in March 2020 in the [[New England Journal of Medicine]].((Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., Diaz, G., Cohn, A., Fox, L., Patel, A., Gerber, S. I., Kim, L., Tong, S., Lu, X., Lindstrom, S., & Pallansch, M. A. (2020). //First Case of 2019 Novel Coronavirus in the United States.// New England Journal of Medicine, 382(10), 929–936. https://doi.org/10.1056/nejmoa2001191)) Cohn was a co-author on the study identifying the first [[SARS-CoV-2]] infection in the United States, published in March 2020 in the [[New England Journal of Medicine]].((Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., Diaz, G., Cohn, A., Fox, L., Patel, A., Gerber, S. I., Kim, L., Tong, S., Lu, X., Lindstrom, S., & Pallansch, M. A. (2020). //First Case of 2019 Novel Coronavirus in the United States.// New England Journal of Medicine, 382(10), 929–936. https://doi.org/10.1056/nejmoa2001191))
 +
 +===== External links =====
 +
 +  * [[https://wiki.whiteroseintelligence.com/en/Amanda-Cohn|White Rose Wiki]]
Back to top